Sign In
Buy DGX
$235.84
+2.12 (+0.91%)
At Close: Aug 05, 2026
FDA brings lab tests under federal oversight in bid to improve accuracy and safety
07:21pm, Monday, 29'th Apr 2024
WASHINGTON — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorou
Quest Diagnostics (DGX) Q1 Earnings Top Estimates, Margins Down
10:56am, Tuesday, 23'rd Apr 2024
Quest Diagnostics (DGX) continues its strong momentum of base business revenue growth in the first quarter of 2024.
Quest Diagnostics (DGX) Beats Q1 Earnings and Revenue Estimates
08:56am, Tuesday, 23'rd Apr 2024
Quest Diagnostics (DGX) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $2.04 per share a year ago.
Quest Diagnostics raises 2024 profit and revenue forecast on strong demand
08:02am, Tuesday, 23'rd Apr 2024
Laboratory operator Quest Diagnostic raised its 2024 profit and revenue forecast on Tuesday after beating first-quarter estimates on robust demand for its diagnostic tests.
Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
06:45am, Tuesday, 23'rd Apr 2024
First quarter revenues of $2.37 billion, up 1.5% from 2023 First quarter reported diluted earnings per share ("EPS") of $1.72, down 3.4% from 2023; and adjusted diluted EPS of $2.04, flat with 2023 Fu
Unlocking Q1 Potential of Quest Diagnostics (DGX): Exploring Wall Street Estimates for Key Metrics
10:21am, Monday, 22'nd Apr 2024
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Quest Diagnostics (DGX), delve into some of its key metrics to gain a deeper insight into the company's potential performance f
Company's AD-Detect™ Portfolio Offers AB 42/40 and Other Plasma Biomarker Testing, Alongside Traditional Cerebrospinal Fluid and Genetic Tests, to Provide Robust Offering in Brain Health SECAUCUS, N
Earnings Preview: Quest Diagnostics (DGX) Q1 Earnings Expected to Decline
11:06am, Tuesday, 16'th Apr 2024
Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quest Diagnostics (DGX) to Post Q1 Earnings: What's in Store?
10:51am, Monday, 15'th Apr 2024
Acquisitions and partnerships with health plans are expected to drive Quest Diagnostics' (DGX) base business performance in the first quarter of 2024.
Quest Diagnostics (DGX) Collaborates With Broad Clinical Labs
12:26pm, Wednesday, 03'rd Apr 2024
Quest Diagnostics (DGX) collaboration is intended to demonstrate the clinical value of WGS as a first-line genetic test for postnatal diagnosis of developmental delay disorders.
Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay
07:57am, Tuesday, 02'nd Apr 2024
Aim to demonstrate whole genome sequencing can replace the standard diagnostic cascade, for potentially faster diagnosis and lower costs SECAUCUS, N.J. , April 2, 2024 /PRNewswire/ -- Quest Diagnosti
8 Upcoming Dividend Increases
09:11pm, Thursday, 28'th Mar 2024
A list of top stocks expected to raise dividends in the upcoming week, with increases averaging 8.4% and median 6.8%. Companies included in the list have consistently grown their dividends for at leas
Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024
03:06pm, Tuesday, 19'th Mar 2024
SECAUCUS, N.J., March 19, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report first quarter 2024 financial resul
Quest Diagnostics' (DGX) New Pact to Reduce Food Insecurity
01:21pm, Tuesday, 27'th Feb 2024
Quest Diagnostics' (DGX) recent collaboration aims to advance food access and healthy eating habits for underserved communities.
Quest Diagnostics to Speak at the Barclays 26th Annual Global Healthcare Conference
09:35am, Friday, 23'rd Feb 2024
SECAUCUS, N.J. , Feb. 23, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and Chief Fi
